Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
Recruiting
18 years - 99 years
Male
Phase
N/A
100 participants needed
1 Location
Brief description of study
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Prostate Cancer,Cancer
-
Age: 18 years - 99 years
-
Gender: Male
Males, 18 years of age, Recently diagnosed with prostate cancer
Updated on
04 Aug 2024.
Study ID: 833499